P&T
Our
Other
Journal
MediMedia Managed Markets

 

Phase 2 Study of Intralesional PV-10 (Rose Bengal) in Metastatic Melanoma

Phase 2 Study of Intralesional PV-10 (Rose Bengal) in Metastatic Melanoma

Sanjiv Agarwala, MD, Chief of Medical Oncology and Hematology at St. Luke’s University Health Network in Bethlehem, PA, and Professor of Medicine at Temple University in Philadelphia, PA, discusses several scenarios in which PV-10 might be used if it is ultimately approved for patients with advanced melanoma.